Table 1.
Characteristics | Case | SNORD15B expression# | χ 2 | p | |
---|---|---|---|---|---|
Low | High | ||||
Sex | 0.037 | 0.847 | |||
Female | 206 | 102 | 104 | ||
Male | 224 | 113 | 111 | ||
Age (yr) | 9.076 | 0.003∗ | |||
≤70 | 230 | 130 | 100 | ||
>70 | 198 | 83 | 115 | ||
TNM stage (AJCC) | 0.228 | 0.633 | |||
Stage I/II | 238 | 116 | 122 | ||
Stage III/IV | 186 | 95 | 91 | ||
Lymphatic invasion | 3.901 | 0.048∗ | |||
Negative | 236 | 129 | 107 | ||
Positive | 151 | 67 | 84 | ||
Venous invasion | 0.056 | 0.813 | |||
Negative | 278 | 141 | 137 | ||
Positive | 94 | 49 | 45 | ||
History of colon polyps | 17.532 | < 0.001∗ | |||
Negative | 239 | 132 | 107 | ||
Positive | 122 | 39 | 83 |
AJCC = American Joint Committee on Cancer. #Cutoff threshold of SNORD15B expression was median value in all patients in this cohort. ∗p < 0.05.